Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Levothyroxine suppressive therapy: harmful and useless or harmless and useful?

Literature DB >> 7868810

Levothyroxine suppressive therapy: harmful and useless or harmless and useful?

L Bartalena¹, A Pinchera.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1994 PMID： 7868810 DOI： 10.1007/BF03349686

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

× No keyword cloud information.

15 in total

1. Thyroid hormones and bone mass.

Authors: D T Baran; L E Braverman
Journal: J Clin Endocrinol Metab Date: 1991-06 Impact factor: 5.958

Review 2. Papillary thyroid carcinoma: factors influencing prognosis and current therapy.

Authors: E L Mazzaferri
Journal: Semin Oncol Date: 1987-09 Impact factor: 4.929

3. Morbidity, mortality, and quality of life for patients treated with levothyroxine.

Authors: K Petersen; C Bengtsson; L Lapidus; G Lindstedt; E Nyström
Journal: Arch Intern Med Date: 1990-10

Review 4. Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter.

Authors: P E Anderson; P R Hurley; P Rosswick
Journal: Surg Gynecol Obstet Date: 1990-10

Review 5. Levothyroxine therapy in patients with thyroid disease.

Authors: S J Mandel; G A Brent; P R Larsen
Journal: Ann Intern Med Date: 1993-09-15 Impact factor: 25.391

6. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.

Authors: G P Leese; R T Jung; C Guthrie; N Waugh; M C Browning
Journal: Clin Endocrinol (Oxf) Date: 1992-12 Impact factor: 3.478

7. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.

Authors: L Bartalena; E Martino; A Pacchiarotti; L Grasso; F Aghini-Lombardi; L Buratti; G Bambini; M Breccia; A Pinchera
Journal: J Clin Endocrinol Metab Date: 1987-04 Impact factor: 5.958

Levothyroxine suppressive therapy: harmful and useless or harmless and useful?

1. Thyroid hormones and bone mass.

Review 2. Papillary thyroid carcinoma: factors influencing prognosis and current therapy.

3. Morbidity, mortality, and quality of life for patients treated with levothyroxine.

Review 4. Conservative treatment and long term prophylactic thyroxine in the prevention of recurrence of multinodular goiter.

Review 5. Levothyroxine therapy in patients with thyroid disease.

6. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.

7. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients.

8. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.

9. Comparison of placebo with L-thyroxine alone or with carbimazole for treatment of sporadic non-toxic goitre.

Review 10. The cold thyroid nodule: an analysis of diagnostic and therapeutic options.

Review 1. Is thyroxine during lithium therapy necessary?

Review 2. Adverse effects of thyroid hormone preparations and antithyroid drugs.